SDIC Fund Management

Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions.

Tianmei Times is a subsidiary of Techcomp ( Tianmei Group). Tianmei Times focusing on the fields of spectroscopy, chromatograph and mass spectrometry, life science laboratory equipment, etc.

Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals.

NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company focuses on developing advanced systems such as the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. NASN is dedicated to integrating research and development with production and sales, aiming to enhance vehicle safety and intelligence. By providing innovative solutions, NASN Automotive Electronics supports the growing demand for advanced driver assistance systems and contributes to the evolution of autonomous driving in China.

Estun Codroid is a technology company specializing in the development and application of generic intelligent robot technology. It focuses on promoting embodied intelligence, offering a range of general intelligent human-machine collaboration robot products and application solutions to cater to diverse markets, including industry and services.

Beijing Shenzhou Puhui Technology is a high-tech company that specializes in AI big data, simulation training, and marine technology. Since its founding, it has focused on technology creation, technical consulting services, and the sale of associated products, all while advancing technological research and development and aiming for client success. Adhere to the combination of indigenous innovation and imported innovation, deliver world-class goods and expert services to the manufacturing, scientific research, and education sectors, aid users in enhancing their research and development capabilities and efficiency, and advance regional technological advancement.

Calterah specializes in the development of CMOS single-chip millimeter-wave radar sensors designed for automotive applications. The company focuses on providing system-on-chip (SoC) products that incorporate radar signal processing baseband technology, facilitating the development and implementation of millimeter-wave radar sensors. These sensors are versatile and find applications in both industrial and consumer sectors, contributing to technologies related to environmental sensing, autonomous obstacle avoidance, autonomous driving, and radar imaging. Calterah's innovations in radar sensor technology position it at the forefront of advancements in automotive safety and automation.

Newcosemi Technology is a Chinese-owned integrated circuit (IC) design firm specializing in the development and manufacture of mid-to-high-end communication chips and high-definition display circuits. The company leverages its proprietary core technology to create advanced IC solutions for enterprise-level communications and high-resolution electronic displays, primarily serving smartphone and television manufacturers seeking to integrate cutting-edge technology into their products.

Mitro Biotech is a domestic molecular imaging medical research and development outsourcing enterprise that specializes in contract research services aimed at shortening the drug development cycle and minimizing the risk of failure. The company offers a comprehensive suite of solutions for both domestic and international pharmaceutical companies and research institutions. Its services encompass drug screening, biodistribution studies, pharmacokinetic research, and pharmacodynamic evaluation, thereby facilitating the efficient introduction of new drugs to the market. By providing these essential services, Mitro Biotech enables pharmaceutical developers to expedite the transition of their products from the research phase to clinical trials and eventual market launch.

Simcere Pharmaceutical Group is a prominent manufacturer and distributor of pharmaceuticals based in Nanjing, China, founded in 1995. The company has transitioned from a distributor to a leading player in China's pharmaceutical market, operating five GMP-certified manufacturing facilities and maintaining a strong workforce of over 4,000 employees. Simcere's product portfolio encompasses a wide range of medications targeting various therapeutic areas, including oncology, nervous system diseases, autoimmune disorders, and infections. Notable products include recombinant human endostatin injection for lung cancer, edaravone for acute cerebral infarction, and various formulations of amoxicillin for infections. The company also develops treatments for conditions such as arthritis, diarrhea, and cardiovascular diseases. Simcere has established strategic partnerships with organizations like Bristol-Myers Squibb and Jiangsu Alphamab Biopharmaceuticals to enhance its research and development capabilities.

News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.

Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.

Zhejiang Xinglaihe is a modern agricultural machinery manufacturing company. It is committed to the research and development, manufacturing, and sale of high-speed rice transplanters, tractors, diesel engines, and other agricultural machinery.

Tongxing Intelligence is a manufacturer of domestic self-contained automotive bus tool chains. They offer reliable products, complete services, and reasonable prices. It has provided independent, innovative solutions to engineering problems in automotive research and development, manufacturing, and industrial production for over two decades.

Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

Shunke Zhilian is a manufacturer of accessories for electric vehicles. It is a national high-tech enterprise integrating R&D, design, manufacturing, sales and after-sales service.

KHAT is a developer and producer of electronically controlled suspension for passenger vehicles.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Rfgene is a company dedicated to research and development in agricultural biotechnology, specializing in the creation and promotion of crops resistant to insects and pests. The organization engages in functional gene mining and the development of transformation bodies, as well as the screening and safety evaluation of genetically modified varieties. Rfgene aims to cultivate a new generation of crop varieties, contributing to advancements in agricultural practices both domestically and internationally. Through its focus on innovative biotechnological solutions, Rfgene seeks to enhance crop resilience and agricultural productivity.

Adlai Nortye Biopharma Co., Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China, specializing in the research and development of innovative oncology therapies. Founded in 2004 and formerly known as Sinopep Pharmaceutical Inc., the company focuses on developing cancer treatments and addressing metabolic diseases. Adlai Nortye operates R&D and clinical operation centers in both China and the United States, emphasizing its global approach to drug development. The company has established a robust pipeline featuring over ten drug candidates, including those in various stages of clinical and preclinical development, such as buparlisib, palupiprant, and AN4005. Through collaborations and internal discoveries, Adlai Nortye seeks to advance its goal of providing effective treatment options for patients with a wide range of tumor types.

CanSemi is a semiconductor manufacturing company based in China, specializing in the production of microprocessors, power management chips, analog chips, and power discrete devices. The company operates as an integrated device manufacturer (IDM), focusing on addressing the domestic demand for chips in various sectors, including the Internet of Things, automotive electronics, industrial control, and 5G technologies. By leveraging its manufacturing capabilities, CanSemi aims to support the growing needs of these advanced industries.

EpimAb Biotherapeutics, based in Shanghai, China, is a biopharmaceutical research and development company focused on creating innovative bispecific antibody therapeutics, particularly for immuno-oncology. Utilizing its proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform, EpimAb develops bispecific antibodies that combine the properties of two different monoclonal antibodies into a single molecule. This unique approach aims to address the limitations of traditional antibody therapies, offering potential solutions for various life-threatening diseases, including cancer. The company recognizes the challenges associated with developing bi-specific antibodies, such as maintaining their drug-like properties and ensuring adequate production. By advancing its pipeline of bispecific therapeutics, EpimAb seeks to meet the growing demand for effective treatment options in the pharmaceutical industry.

Zhejiang Leapmotor Technology Co., Ltd. is an innovative electric vehicle manufacturer based in Hangzhou, China, founded in 2015. The company specializes in the design, research and development, and production of new energy vehicles. It focuses on intelligent electric vehicle technologies, including intelligent driving, motor electronic control, and battery system development. Leapmotor leverages the financial backing and technological expertise of its primary investor, Zhejiang Dahua Technology Co., Ltd., to enhance its research capabilities and quality management processes. The company is committed to technological innovation and industrial design, emphasizing a strong engineering culture to drive its advancements in the electric vehicle sector.

Zylox Medical Device Co., founded in 2012 in Hangzhou, is a specialized company focused on developing innovative medical devices for interventional procedures. Established by a team of experienced professionals with backgrounds in top-tier medical device manufacturers, Zylox offers a diverse range of products primarily aimed at peripheral vascular and neurovascular interventions. Its product line includes various devices such as PTA balloons, drug-coated PTA balloons, superficial femoral artery (SFA) stents, and the Thrombite Clot Retriever Device. Zylox is committed to improving patient outcomes by consistently enhancing its cutting-edge medical technologies and ensuring the highest quality standards.

Jianan Nongmu builds a new model of the agriculture and animal husbandry industry. The company is divided into three business units: digital supply chain financing, smart breeding, and smart logistics. Jianan Nongmu is dedicated to bringing back the agriculture and animal husbandry sectors of the economy through science and technology.

Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.

Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.

Peijia Medical Limited is a medical device company based in Suzhou, China, that specializes in the research, development, production, and sales of interventional procedural devices aimed at treating structural heart and neurovascular diseases. Founded in 2012, the company focuses on innovative products including various generations of transcatheter aortic valve replacement systems, as well as devices for transcatheter mitral and tricuspid valve replacements. In addition to its core offerings in heart valve therapies, Peijia Medical is advancing a range of ancillary products such as lithotripsy and balloon aortic valvuloplasty catheters, guidewires, and mitral repair devices. The company's neurointerventional product line includes stent retrievers, aspiration catheters, and detachable coils. With a commitment to high-quality medical technologies, Peijia Medical operates within a modern facility that supports its extensive R&D efforts in the growing interventional medical device market.

EpimAb Biotherapeutics, based in Shanghai, China, is a biopharmaceutical research and development company focused on creating innovative bispecific antibody therapeutics, particularly for immuno-oncology. Utilizing its proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform, EpimAb develops bispecific antibodies that combine the properties of two different monoclonal antibodies into a single molecule. This unique approach aims to address the limitations of traditional antibody therapies, offering potential solutions for various life-threatening diseases, including cancer. The company recognizes the challenges associated with developing bi-specific antibodies, such as maintaining their drug-like properties and ensuring adequate production. By advancing its pipeline of bispecific therapeutics, EpimAb seeks to meet the growing demand for effective treatment options in the pharmaceutical industry.

Qingtuanshe, founded in 2013, is a university part-time employment and flexible platform that is committed to more users. Qingtuanshe offers safer, richer, and more efficient part-time services to professional part-time recruitment services for more companies. As of January 2019, the registered users of Qingtuanshe is 6 million+, the number of registered companies is 100,000+, and the number of part-time applicants per day reached 240,000.

Zylox Medical Device Co., founded in 2012 in Hangzhou, is a specialized company focused on developing innovative medical devices for interventional procedures. Established by a team of experienced professionals with backgrounds in top-tier medical device manufacturers, Zylox offers a diverse range of products primarily aimed at peripheral vascular and neurovascular interventions. Its product line includes various devices such as PTA balloons, drug-coated PTA balloons, superficial femoral artery (SFA) stents, and the Thrombite Clot Retriever Device. Zylox is committed to improving patient outcomes by consistently enhancing its cutting-edge medical technologies and ensuring the highest quality standards.

FitSAMO is an orthopaedic surgical equipment supplier.

Banma Network Technologies is a global vehicle solution platform focused on the automotive and transportation industries. The company specializes in developing smart car operating systems and digital transportation solutions, aiming to enhance the connectivity and functionality of vehicles. By offering its AliOS in-car operating system to developers and car manufacturers, Banma seeks to facilitate the integration of connected car technologies, ultimately optimizing the user experience in smart mobility. Through its innovative services, Banma Network is committed to realizing the full potential of connected vehicles and transforming the travel industry.

Xinjinghe Laser Technology Development (Beijing) Co., Ltd. is a company that focuses on high-end manufacturing industries such as aerospace, navigation, and nuclear power. It specializes in complicated metal component customisation, product design and optimization, and software customization. Development and sales, technical advice and services, product remanufacturing and repair, 3D printing equipment manufacturing and sales of national high-tech businesses, is China's leading provider of metal additive/subtractive manufacturing technology comprehensive solutions.

RootCloud is a Beijing-based cloud computing platform founded in 2016, specializing in industrial Internet-of-Things (IoT) applications. It offers a comprehensive solution that encompasses various layers, including connection, platform, and application layers, aimed at enhancing industrial operations. The company primarily serves machine manufacturers, equipment users, government agencies, and social organizations, providing services such as smart manufacturing, research and development, and equipment financing. RootCloud leverages its extensive expertise in IoT and big data to support digital transformation and life-cycle management for large-scale manufacturing enterprises. By delivering service-as-a-service applications on public cloud infrastructure, RootCloud enables clients to improve operational efficiency and product quality, fundamentally reshaping the way industrial enterprises manage their businesses.

LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.

Xinjinghe Laser Technology Development (Beijing) Co., Ltd. is a company that focuses on high-end manufacturing industries such as aerospace, navigation, and nuclear power. It specializes in complicated metal component customisation, product design and optimization, and software customization. Development and sales, technical advice and services, product remanufacturing and repair, 3D printing equipment manufacturing and sales of national high-tech businesses, is China's leading provider of metal additive/subtractive manufacturing technology comprehensive solutions.

Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. They discover new medicines using novel disease specific targets and innovative technologies. The patented discoveries are then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not the symptoms. Zensun’s current pipeline covers cardiovascular disease treatment, anti-cancer drugs, and treatments for energy metabolism disorders.

Ninebot Inc. is a company that specializes in the design, development, manufacturing, distribution, and sale of short-distance personal transportation products. Founded in 2012 and headquartered in Beijing, China, Ninebot focuses on providing eco-friendly, electric, and self-balancing vehicles tailored for short-range commuting. The company serves a diverse customer base through a network of distributors and retail points both in China and internationally.

United Imaging Healthcare develops and manufactures a wide range of medical equipment and solutions, focusing on diagnostic imaging, radiotherapy, and healthcare information technology. The company's product offerings include advanced imaging devices such as computed tomography, molecular imaging, magnetic resonance systems, and digital radiography solutions. Notable products include the uCT 510, uMI 510 PET-CT scanner, and uMR 560 imaging device. Additionally, United Imaging provides the uCloud UIH Intelligent Medical Cloud platform for resource sharing and data analysis. The company also offers comprehensive customer support, technical assistance, and training services. Established in 2011 and headquartered in Shanghai, China, United Imaging Healthcare has expanded its operations to various locations, including the United States, with facilities in cities like Concord, Cleveland, and Houston. The company has strategic partnerships to enhance its offerings and reach in the healthcare sector.

CF PharmTech, Inc. is an independent specialty pharmaceutical company founded in 2007 and headquartered in Suzhou, China. The company specializes in the development and manufacturing of inhalation products, including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. CF PharmTech focuses on creating high-quality and affordable medications for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. In addition to its product development efforts, the company provides contract manufacturing organization (CMO) services, enhancing its capabilities in the global market. With a commitment to effective patient care, CF PharmTech aims to improve management of respiratory conditions through its innovative offerings.

Novus Pharmaceuticals is a technology platform. The company provides solid oral preparations and human nutrition and health care products. The company's products dosage forms include sterile powder injection, sterile water injection, hard capsule, and tablet. They help people.

CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

Maxwell Technologies specializes in the development, manufacturing, and marketing of energy storage and power delivery solutions. Its products cater to various sectors, including automotive, heavy transportation, renewable energy, backup power, wireless communications, and industrial and consumer electronics. The company is known for producing ultra-high-voltage capacitors, as well as truck and generator starting capacitors, which are designed to deliver cost-effective, energy-efficient, and environmentally friendly performance. Maxwell Technologies aims to ensure failure-free operation throughout the lifespan of its products, even in the most demanding applications, and also develops radiation-hardened microelectronic components and systems for satellites and spacecraft.

Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.

Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for cancer, hepatitis B virus (HBV), and age-related diseases. Founded in 2009 and headquartered in Suzhou, China, the company has established a diverse pipeline of drug candidates, including HQP1351, a BCR-ABL/KIT inhibitor targeting resistant mutations, and APG-2575, an orally administered Bcl-2 selective inhibitor for hematologic malignancies. Additional candidates include APG-1252, aimed at restoring apoptosis in various solid tumors, and APG-115, which targets the MDM2-p53 interaction in solid tumors and lymphoma. Ascentage Pharma also develops APG-1387 for advanced solid tumors and chronic HBV infection, alongside other therapies for non-small-cell lung carcinoma and chronic lymphocytic leukemia. The company has entered into clinical collaborations to explore innovative treatment combinations, furthering its commitment to addressing challenging diseases in the oncology landscape.

Novogene Co., Ltd. is a prominent global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics. Founded in 2011 and headquartered in Beijing, China, the company operates with a large workforce and boasts the highest sequencing capacity worldwide. Novogene offers a wide range of genomic solutions, including human genome sequencing, cancer genomic profiling, and various applications for animals, plants, and microbes. Their advanced services also encompass clinical-grade whole exome sequencing and specialized diagnostic assays for cancer therapies. The company is recognized for its commitment to data quality and customer service, having produced over 1850 research papers in prestigious journals. Dr. Ruiqiang Li, the founder and a leading expert in genomics, has significantly contributed to the field through multiple patents and influential publications, fostering Novogene's reputation as a leader in the genomics sector.

Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.

GBase is a provider of database software solutions based in China, specializing in the development of products tailored for various industries, including finance, telecommunications, government, energy, transportation, and national defense. The company focuses on enabling enterprises to utilize domestically developed software, which supports their operational needs and enhances data management capabilities. GBase's offerings are designed to meet the specific requirements of its clients, facilitating improved performance and efficiency in data handling across diverse sectors.

Duzhe is an application that provides a catalog of magazines. They have formed a range of journals. The company's contact mode is at its physical address.

JLand Biotech specializes in the development and manufacturing of Biollagen™, a non-animal sourced collagen produced through advanced bioengineering techniques like genetic recombination and microbial fermentation. The company aims to become the world's leading supplier of non-animal collagen, catering primarily to industries such as cosmetics and food.